홈 › 급성 골수성 백혈병 › 미주리
미주리의 급성 골수성 백혈병 임상 시험
급성 골수성 백혈병 관련 연구 24개가 미주리 내 여러 지역에서 참여자를 모집하고 있습니다.
미주리의 도시
공식 연구 텍스트(영어)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 외 2개
피험자 모집 중2상
18세 ~ 59세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05554393Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 외 2개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06484062A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Washington University in St Louis, St Louis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Parkland Health Center - Farmington, Farmington
- 외 10개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05564390A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
- Washington University /ID# 280295, St Louis
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07581002Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 외 2개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06317649Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 외 2개
피험자 모집 중2상
18세 ~ 59세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT05554406A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- Children's Mercy Hospitals and Clinics, Kansas City
- Washington University School of Medicine, St Louis
- Mercy Hospital Saint Louis, St Louis
피험자 모집 중3상
6 Months – 21 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT04293562A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Washington University in St. Louis School of Medicine, St Louis
피험자 모집 중1/2상
30 Days · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT04065399A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- Washington University in St. Louis, St Louis
피험자 모집 중관찰 연구
0세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07154823Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- 외 21개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
- US-St Louis MO-WASHU, St Louis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07223814Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
- Washington University in St Louis, St Louis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06533761The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Missouri Children's Hospital, Columbia
- Children's Mercy Hospitals and Clinics, Kansas City
- Cardinal Glennon Children's Medical Center, St Louis
- 외 2개
피험자 모집 중1/2상
22세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04726241Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- The Children's Mercy Hospital - Adele Hall Campus, Kansas City
- Washington University School of Medicine in St. Louis, St Louis
피험자 모집 중3상
29 Days – 21 Years · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05183035Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
- Washington University School of Medicine, St Louis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT06158828Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Washington University School of Medicine, St Louis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06001788Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- Washington University, St Louis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06529731Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Children's Mercy Hospital of Kansas City, Kansas City
피험자 모집 중1상
1세 ~ 30세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06177067Motixafortide for MRD Sensitization in AML
- Washington University School of Medicine, St Louis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07392970A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's Mercy Hospital and Clinics, Kansas City
- Cardinal Glennon Children's Medical Center, St Louis
- Washington University St. Louis, St Louis
- 외 1개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Washington University School of Medicine, Siteman Cancer Center, St Louis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 8. 업데이트됨 · NCT06419634A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Washington University in St. Louis, St Louis
피험자 모집 중1상
12세 이상 · 모든 성별 · 2026. 3. 16. 업데이트됨 · NCT06994676Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
- Washington University School of Medicine, St Louis
피험자 모집 중건강한 지원자 환영
18세 이상 · 모든 성별 · 2025. 10. 16. 업데이트됨 · NCT04986657ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.